The U.S. Food and Drug Administration approved Foundayo (orforglipron), a weight loss medication, 50 days after filing under the Commissioner's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE